Profile	GDS4460 / 1556827_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	16.3	35
GSM803589	patient 7, baseline	35.2	49
GSM803592	patient 8, baseline	19.6	36
GSM803595	patient 10, baseline	1.9	5
GSM803598	patient 11, baseline	13.5	31
GSM803601	patient 12, baseline	11.3	26
GSM803604	patient 13, baseline	18.2	37
GSM803607	patient 14, baseline	17.9	34
GSM803610	patient 15, baseline	14.6	31
GSM803613	patient 16, baseline	42.2	55
GSM803587	patient 6, arm treated with pimecrolimus	14.7	34
GSM803590	patient 7, arm treated with pimecrolimus	34.9	50
GSM803593	patient 8, arm treated with pimecrolimus	1.1	2
GSM803605	patient 13, arm treated with pimecrolimus	25.2	44
GSM803608	patient 14, arm treated with pimecrolimus	19.8	39
GSM803599	patient 11, arm treated with pimecrolimus	22.1	41
GSM803611	patient 15, arm treated with pimecrolimus	9.7	25
GSM803614	patient 16, arm treated with pimecrolimus	11.9	29
GSM803602	patient 12, arm treated with pimecrolimus	27.1	41
GSM803596	patient 10, arm treated with pimecrolimus	33.4	44
GSM803591	patient 8, arm treated with betamethasone	4.5	17
GSM803609	patient 15, arm treated with betamethasone	40.2	48
GSM803597	patient 11, arm treated with betamethasone	4	13
GSM803585	patient 6, arm treated with betamethasone	34.8	46
GSM803603	patient 13, arm treated with betamethasone	27.5	43
GSM803612	patient 16, arm treated with betamethasone	10.9	24
GSM803588	patient 7, arm treated with betamethasone	20.5	34
GSM803594	patient 10, arm treated with betamethasone	13.5	28
GSM803600	patient 12, arm treated with betamethasone	41.8	50
GSM803606	patient 14, arm treated with betamethasone	10.2	24